Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China flag China · Delayed Price · Currency is CNY
34.37
+1.19 (3.59%)
Mar 10, 2026, 1:45 PM CST
62.74%
Market Cap 22.63B
Revenue (ttm) 1.67B
Net Income (ttm) 225.09M
Shares Out 733.37M
EPS (ttm) 0.32
PE Ratio 103.94
Forward PE 42.54
Dividend 0.03 (0.08%)
Ex-Dividend Date Aug 14, 2025
Volume 10,996,723
Average Volume 13,075,835
Open 33.27
Previous Close 33.18
Day's Range 33.27 - 34.61
52-Week Range 15.12 - 45.95
Beta 0.98
RSI 39.18
Earnings Date Mar 31, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603127
Full Company Profile

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial Statements

News

There is no news available yet.